BENF.NASDAQBeneficient

DEF 14A: Beneficient Seeks Stockholder Approval to Increase Authorized Class A Common Stock Amid Liquidity and Capital Needs

Sentiment:

Proxy Statement


Beneficient is asking stockholders to approve an amendment to its Articles of Incorporation to increase the number of authorized shares of Class A common stock from 18,750,000 to 5,000,000,000 to support its business plan, liquidity transactions, and potential capital raising activities.

Capital raiseThe company is seeking to increase the number of authorized shares of Class A common stock to facilitate potential capital raising activities.The company has a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. for up to $250 million, with $246.1 million remaining available, but may not be able to access the full amount without the share increase.

Summary

  • Beneficient is holding a Special Meeting of Stockholders on October 2, 2024, to vote on two proposals.
  • The first proposal seeks to increase the number of authorized shares of Class A Common Stock from 18,750,000 to 5,000,000,000.
  • The second proposal is to approve an adjournment of the Special Meeting if there are insufficient votes for the first proposal.
  • The Board of Directors recommends voting FOR both proposals.
  • The company needs more authorized shares to execute its business plan, which includes financing liquidity for alternative assets, raising capital, and providing equity incentives.
  • Failure to approve the share increase could hinder the company's ability to complete liquidity transactions, raise capital, and attract talent.
  • As of September 9, 2024, there were 4,228,488 shares of Class A Common Stock and 239,257 shares of Class B Common Stock outstanding.
  • The company has a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. for up to $250 million, with $246.1 million remaining available, but may not be able to access the full amount without the share increase.
  • Certain securities of Beneficient Company Holdings, L.P. (BCH) are exchangeable for shares of Class A Common Stock, and the Exchange Agreement limits conversion of such securities until the Company has sufficient available shares.
  • The Authorized Shares Proposal requires (i) the affirmative vote of the holders of at least a majority of the voting power of the Company's outstanding capital stock entitled to vote thereon and (ii) the affirmative vote of the holders of Class B Common Stock, voting as a separate class, which we expect to obtain by written consent.
  • The Adjournment Proposal requires the affirmative vote of a majority of the votes cast at the Special Meeting.

Sentiment

Score: 6

Explanation: The document is neutral in tone, outlining the need for a share increase to support the company's business plan. While the company highlights the potential benefits of the increase, it also acknowledges the potential dilutive effects on existing stockholders. The sentiment is slightly positive due to the potential for growth and flexibility, but tempered by the inherent risks and uncertainties.

Positives

  • The Board believes increasing the number of authorized shares is in the best interest of stockholders and the Company.
  • Approval of the Authorized Shares Amendment would provide greater flexibility to the Board in considering and planning for potential future corporate needs.
  • The company has a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. for up to $250 million, with $246.1 million remaining available.

Negatives

  • Future issuances of Class A Common Stock or securities convertible into our Class A Common Stock could have a dilutive effect on the earnings per share, book value per share, voting power and percentage interest of holdings of current stockholders.
  • The availability of additional shares of our Class A Common Stock for issuance could, under certain circumstances, discourage or make more difficult efforts to obtain control of the Company under a possible take-over scenario.
  • If the Company does not have sufficient unreserved, authorized shares we would encounter greater difficulty in carrying out our business strategy because we may be unable to (i) complete our ordinary course liquidity transactions, (ii) raise capital by issuing shares of our Class A Common Stock or securities convertible into Class A Common Stock, or (iii) provide equity incentives to employees, officers, directors, customers, consultants, or advisors.

Risks

  • Failure to approve the share increase could hinder the company's ability to complete liquidity transactions, raise capital, and attract talent.
  • If the company is limited in its ability to raise additional capital under the SEPA or through other means, it may not be able to execute on its strategic plans.
  • The company may need to seek alternative sources of capital to fund its operations, which may not be available on favorable terms, or at all.
  • There is no assurance that the company would be successful in raising funds in the future or that such funds could be raised at prices that would not create substantial dilution for existing stockholders.
  • If the company is unable to raise additional capital, then it may have difficulty entering into liquidity transactions, which would lead to a decrease in revenues and adversely affect operations and business plans.

Future Outlook

The company anticipates using the additional authorized shares for various purposes, including financing liquidity transactions, raising capital through offerings of Common Stock or securities that are convertible into Class A Common Stock, including sales of Class A Common Stock pursuant to the SEPA, issuing Common Stock upon conversion or exercise of outstanding convertible securities, including securities of BCH, providing equity incentives to employees, officers, directors, customers, consultants, or advisors, stock splits, dividends, and similar transactions, debt or equity restructuring or refinancing transactions and other general corporate purposes.

Management Comments

  • The Board considers it advisable and in the best interests of the Company and its stockholders to have a sufficient number of unissued and unreserved authorized shares of Class A Common Stock in order for us to operate our business plan.
  • The Board believes that if the number of shares of the Company's Common Stock voted is insufficient to approve the Authorized Shares Proposal, it is in the best interests of the stockholders to enable the Board to continue to seek to obtain a sufficient number of additional votes to approve the Authorized Shares Proposal.

Industry Context

Many companies seek to increase their authorized share count to provide flexibility for future capital raising, acquisitions, and employee compensation. This move by Beneficient is consistent with that trend, particularly for companies in growth phases or those requiring significant capital for operations.

Comparison to Industry Standards

  • Increasing authorized shares is a common practice among publicly traded companies to provide flexibility for future corporate actions.
  • Comparable companies in the financial services or alternative asset management sectors often maintain a significant buffer of authorized but unissued shares to facilitate potential acquisitions, strategic investments, or capital raises.
  • For example, companies like Blackstone or Apollo Global Management regularly utilize their authorized shares for strategic purposes.

Stakeholder Impact

  • Approval of the Authorized Shares Amendment would not have any immediate dilutive effect on the proportionate voting power or other rights of existing stockholders.
  • Future issuances of Class A Common Stock or securities convertible into our Class A Common Stock could have a dilutive effect on the earnings per share, book value per share, voting power and percentage interest of holdings of current stockholders.
  • Maintaining an adequate number of authorized shares reserved for awards made pursuant to the equity incentive plans allows us to attract, incentivize, and retain qualified employees, directors, and consultants.

Next Steps

  • Stockholders are requested to vote on the proposals outlined in the Proxy Statement.
  • The Company intends to file the Authorized Shares Amendment with the Nevada Secretary of State promptly following the Special Meeting if the proposal is approved.
  • The Company expects to publish the voting results of the Special Meeting in a Current Report on Form 8-K within four business days following the date of the Special Meeting.

Key Dates

DateDescription
June 27, 2023Date of the Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd.
June 6, 2023The Company converted from a Delaware limited partnership called The Beneficient Company Group, L.P. to a Nevada corporation called Beneficient in connection with the closing of its merger with Avalon Acquisition Inc.
September 9, 2024Record date for determining stockholders entitled to notice of and to vote at the Special Meeting.
September 20, 2024Date of mailing the Notice of Meeting and Proxy Statement.
October 1, 2024Deadline to vote via Internet or telephone (11:59 p.m. Central Time).
October 2, 2024Date of the Special Meeting of Stockholders at 9:00 a.m., Central Time.

Keywords

authorized shares, Class A Common Stock, proxy statement, special meeting, Beneficient, capital raising, liquidity transactions, SEPA, stockholders

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.